/Investor DB

Asset Management Ventures — Full Portfolio

10 tracked investments · listed companies and verified rows first

Aaviaaavia.io𝕏Jan 2021

Aavia is a mobile app that helps people with ovaries track and understand how their hormones impact their health, mood, and productivity.

ConsumerDigital HealthFemTechHealthtechWellness & Fitness

Aagya Mathur(Founder)inAya Suzuki(Founder)inAlexis Wong(Founder)

Co-investors37 AngelsAsset Management CompanyBantam GroupDorm RoomPopstar VenturesSeven Seven Six+5 more

Autonomizeautonomize.aiinSeed · Apr 2023 · $4M

Autonomize builds an AI operating layer for healthcare enterprises that structures unstructured data, grounds decisions in clinical and policy evidence, and orchestrates workflows through healthcare-native AI agents working alongside human experts.

AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechAustin, US

Ganesh Padmanabhan(Founder)inKris Nair(Executive Officer, Director)in

BoardMike Spadafore(Director)inDavid Fleshman(Director)

Co-investorsAsset Management CompanyATX Venture PartnersLoop VCTau Ventures

Carta Healthcarecarta.healthcareinSeries A · Mar 2019

Unable to determine company information; page contains only placeholder Lorem ipsum text.

AI & Machine LearningDigital HealthHealthtechPittsburgh, US

Gilan El Saadawi(Executive Officer, Director, Promoter)Betsy Castillo(Head of Clinical Data Abstraction)inMichael Finke(Director)Brenton Burns(Director)Scot Stevens(Director)Aaron Brauser(Executive Officer, Director, Promoter)

Co-investorsAsset Management CompanyCU Healthcare Innovation FundFrist Cressey VenturesHealthy VenturesKatalyst VenturesKatalyst.Ventures+9 more

Endless healthbesthearttest.cominSeed · Jul 2024 · $5M

Endless Health provides an all-in-one platform and strategic support for wellness professionals to launch and scale preventive health practices, combining precision lab testing, practice management software, and personalized coaching infrastructure.

HealthtechSaaSWellness & FitnessAustin, US

Cooper Galvin(Executive Officer, Director)

Co-investorsAsset Management CompanyNext Coast VenturesAntler

Indi Molecularindimolecular.cominJun 2017 · $11.5M

Indi Molecular develops small-molecule oncology therapeutics based on protein-catalyzed capture agents (PCCs) created through click chemistry, a synthetic process developed in collaboration with Caltech.

BiotechDeep TechMedical DevicesCulver City, US

James Heath(Director)Leroy Hood(Director)Andreas Jurgeit(Director)inHeather Agnew(Executive Officer)Albert Luderer(Executive Officer, Director)Darren Cai(Director)

Co-investorsLegend CapitalM VenturesAsset Management Company

Outcomes4Meoutcomes4me.comin𝕏Seed · Apr 2021 · $12M

Outcomes4Me is an AI-driven patient platform that integrates with NCCN clinical oncology guidelines to provide personalized cancer care guidance, treatment options, clinical trial recommendations, and genetic testing information.

AI & Machine LearningDigital HealthHealthtechCambridge, US

Maya R. Said(Founder and CEO)inOsama Rahma(Founder)inMaya R. Said, Sc.D.(Founder and CEO)

BoardAndrea Jackson(Director)inDavid Fleshman(Director)David Auckland(Director)

Co-investorsAsset Management CompanyHealthX VenturesSierra VenturesNorthpond Ventures

SubjectWellsubjectwell.cominSeries B · Oct 2022 · $35M

SubjectWell operates a patient network that links individuals to clinical trials and connects them with healthcare providers and pharmaceutical sponsors.

BiotechDigital HealthHealthtech

Co-investorsAsset Management CompanyATPGeekdomHealthy VenturesMartin VenturesWindham Capital Partners

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

BiomicsMarley MedicalMaverix BiomicsSensOmicsShyld AI

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.